A. Krämer

Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group

M.F. Mosele, C. Benedikt Westphalen, A Stenzinger et al. · Annals of Oncology · 2024 · 345 citations · Full text

Medicine, Oncology, Molecular Oncology +12

Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A. Krämer, Tilmann Bochtler, Chantal Pauli et al. · Annals of Oncology · 2022 · 197 citations · Full text

Medicine, Oncology, Cancer Screening +13

Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

Anuhar Chaturvedi, Lena Herbst, Stefan Pusch et al. · Leukemia · 2017 · 119 citations · Full text

Medicine, Oncology, Pharmacology +10

Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia

Sabine Käyser, Axel Benner, Christian Thiede et al. · Blood Cancer Journal · 2016 · 82 citations · Full text

Medicine, Hematology, Oncology +16

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma

A. Krämer, Silja Schweizer, Kai Neben et al. · Leukemia · 2003 · 75 citations

Life Sciences, Genetics, Oncology +16